News & Publications

ASRM Bulletins

FDA to Host Scientific Workshop on Labeling of Lower-Dose Estrogen Products Used to Treat Symptoms of Menopause

ASRM Bulletins October 08, 2015

The U.S. Food and Drug Administration (FDA) has announced it is seeking public comment on the labeling for lower-dose estrogen products delivered vaginally and intended to treat symptoms of vulvar and vaginal atrophy due to menopause.  It will hold a scientific workshop to seek expert opinions on whether the current “Boxed Warnings” section in the labeling is applicable in whole or in part to these lower-dose estrogen products.

ASRM and SMRU Respond to FDA on Drug Development

ASRM Bulletins October 01, 2015

ASRM and its affiliated society the Society for Male Reproduction and Urology (SMRU) jointly submitted a comment letter regarding draft guidelines the Food and Drug Administration (FDA) has issued entitled, “Testicular Toxicity: Evaluation During Drug Development.”

Registration Open for ASRM Advocacy Academy

ASRM Bulletins September 14, 2015

ASRM will host its inaugural ASRM Advocacy Academy from December 8-10 in Washington, DC.

NICHD Seeks Job Applicants for Branch Chief Position

NIH Announcements September 11, 2015

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is recruiting for a Supervisory Health Scientist Administrator or Medical Officer for the Branch Chief position of the Contraceptive Discovery and Development Branch (CDDB), Division of Extramural Research (DER).

ASRM and SART Released the Following Comments on “Outcomes of Fresh and Cryopreserved Oocyte Donation,”

ASRM Bulletins August 11, 2015

James Toner, MD, SART President remarked, “We appreciate Dr. Kushnir and his colleagues’ sharing their analysis comparing the outcomes of cycles using frozen donor eggs with outcomes of fresh donor egg cycles.

Highlights from Fertility and Sterility - Uterine Transplant/Sperm and Processed Meat

ASRM Bulletins August 05, 2015

Psychological Outcomes for Uterine Transplant Patients Are Good One Year Post-SurgerySwedish researchers have found that uterine transplant patients and their partners are doing well psychologically and do not experience higher levels of anxiety than the general population.Processed Meat Consumption Is Not Good for Sperm’s Fertilizing Ability; Consumption of Poultry Is BeneficialBoston researchers have found that, among infertility patients having IVF, men’s poultry intake is related to better fertilization rates in IVF cycles with and without intracytoplasmic sperm injection (ICSI).

ASRM Mourns the Passing of Dr. Howard Jones

ASRM Bulletins July 31, 2015

All of us within ASRM, and indeed all of us in reproductive medicine around the world, are saddened by the death of Howard Jones.

FDA’s Obstetrics and Gynecology Devices Panel Will Meet on September 24, 2015 to Discuss the Essure System

ASRM Bulletins July 29, 2015

The OB/Gyn Devices Panel of FDA’s Medical Devices Advisory Committee is convening to seek expert scientific and clinical input on the risks and benefits of Bayer HealthCare’s Essure System for permanent female sterilization.

Abortion Politics Shelves Vote on IVF for Vets Bill

ASRM Bulletins July 28, 2015

Legislation (S 469) to extend IVF coverage to veterans with a service-related condition that resulted in the veteran being unable to procreate without the use of the technology was pulled from consideration by the Senate Veterans’ Affairs Committee today due to partisan politics having to do with abortion.

NIH Seeks Comment on National Children’s Study Alternative

ASRM Bulletins July 17, 2015

The National Children’s Study (NCS) was authorized by Congress in 2000 to study environmental influences on child health and development. However, in 2014 the Institute of Medicine (IOM) was asked to review the NCS and issued a report which outlined concerns regarding the study's design, management, oversight structure, and anticipated cost. As a result, the launch of the Main Study for the NCS was put on hold, and an advisory committee to the Director of NIH was tasked with reviewing the feasibility of continuing the NCS. In late 2014, the advisory committee recommended that, while the overall goals of the NCS should remain a priority for future scientific support, the NCS was not feasible as currently outlined. It was soon announced that the NIH would discontinue the NCS.


View Details
Learn More | Join | Renew
Back to Top